Oguzcan Ozkan

Ege, Turkey

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Prognostic factors in avelumab maintenance therapy for metastatic urothelial carcinoma.

Prognostic factors in avelumab maintenance therapy for metastatic urothelial carcinoma.

Journal: Immunotherapy

Published: September 02, 2026

Evaluating the Prognostic Role of Body Fat Density in Colorectal Cancer: A Critical Appraisal.

Evaluating the Prognostic Role of Body Fat Density in Colorectal Cancer: A Critical Appraisal.

Journal: Nutrition and cancer

Published: April 27, 2026

Real-world associations of pathological complete response and survival with neoadjuvant pembrolizumab in early TNBC: a Turkish Oncology Group study.

Real-world associations of pathological complete response and survival with neoadjuvant pembrolizumab in early TNBC: a Turkish Oncology Group study.

Journal: Scientific reports

Published: January 09, 2026

Bevacizumab combined with irinotecan or temozolomide in recurrent glioblastoma: a Turkish Oncology Group (TOG) study.

Bevacizumab combined with irinotecan or temozolomide in recurrent glioblastoma: a Turkish Oncology Group (TOG) study.

Journal: Journal of neuro-oncology

Published: November 21, 2025

Skeletal muscle index as a prognostic biomarker for survival in HER2-positive and triple-negative breast cancer: a retrospective cohort study.

Skeletal muscle index as a prognostic biomarker for survival in HER2-positive and triple-negative breast cancer: a retrospective cohort study.

Journal: BMJ supportive & palliative care

Published: November 14, 2025

Impact of prognostic nutritional index and geriatric nutritional risk index on prognosis in elderly patients with early-stage prostate cancer.

Impact of prognostic nutritional index and geriatric nutritional risk index on prognosis in elderly patients with early-stage prostate cancer.

Journal: Frontiers in nutrition

Published: November 13, 2025

Avelumab maintenance in patients with metastatic urothelial carcinoma in a real-life expanded-access program.

Avelumab maintenance in patients with metastatic urothelial carcinoma in a real-life expanded-access program.

Journal: Future oncology (London, England)

Published: October 17, 2025

GLR in Cholangiocarcinoma: A Practical Biomarker in Need of Validation.

GLR in Cholangiocarcinoma: A Practical Biomarker in Need of Validation.

Journal: Nutrition and cancer

Published: October 11, 2025

Endocrine Therapy versus Chemotherapy After CDK4/6 Inhibitor Progression in HR+/HER2- Metastatic Breast Cancer: A Multicenter Real-World Study from Turkey.

Endocrine Therapy versus Chemotherapy After CDK4/6 Inhibitor Progression in HR+/HER2- Metastatic Breast Cancer: A Multicenter Real-World Study from Turkey.

Journal: Breast cancer (Dove Medical Press)

Published: September 30, 2025

Real-World Predictors of Survival in CDK4/6 Inhibitor-Treated Metastatic Breast Cancer: The Significance of ER Expression Level and Treatment Naivety.

Real-World Predictors of Survival in CDK4/6 Inhibitor-Treated Metastatic Breast Cancer: The Significance of ER Expression Level and Treatment Naivety.

Journal: Current oncology (Toronto, Ont.)

Published: September 27, 2025

Efficacy of Subsequent Therapy in Patients with Hormone-Positive Advanced Breast Cancer with Disease Progression After CDK4/6 Inhibitor Therapy: Multicenter Real-Life Data.

Efficacy of Subsequent Therapy in Patients with Hormone-Positive Advanced Breast Cancer with Disease Progression After CDK4/6 Inhibitor Therapy: Multicenter Real-Life Data.

Journal: Journal of clinical medicine

Published: September 09, 2025

Predicting 10-year survival in early and locally advanced breast cancer: prognostic value of nutritional status and body composition.

Predicting 10-year survival in early and locally advanced breast cancer: prognostic value of nutritional status and body composition.

Journal: Nutrition (Burbank, Los Angeles County, Calif.)

Published: August 11, 2025

Showing 1-12 of 18

Last Updated: 09/26/2026